The American Journal of Medicine
Volume 120, Issue 8 , Pages 720-727 , August 2007

Hemoglobin A1c Predicts Diabetes but Not Cardiovascular Disease in Nondiabetic Women

  • Aruna D. Pradhan, MD

      Affiliations

    • Center for Cardiovascular Disease Prevention, Division of Cardiovascular Medicine, VA Boston Medical Center, Boston, Mass
    • Donald W. Reynolds Center for Cardiovascular Research, Boston, Mass
    • Division of Cardiovascular Medicine, VA Boston Medical Center, Boston, Mass
    • Corresponding Author InformationCorrespondence should be addressed to Aruna D. Pradhan, MD, MPH, Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, 900 Commonwealth Avenue East, Boston, MA 02215-1204.
    • ,
  • Nader Rifai, PhD

      Affiliations

    • Center for Cardiovascular Disease Prevention, Division of Cardiovascular Medicine, VA Boston Medical Center, Boston, Mass
    • Department of Pathology, Children’s Hospital Medical Center and Harvard Medical School, Boston, Mass
    • ,
  • Julie E. Buring, ScD

      Affiliations

    • Center for Cardiovascular Disease Prevention, Division of Cardiovascular Medicine, VA Boston Medical Center, Boston, Mass
    • Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, Mass
    • ,
  • Paul M. Ridker, MD

      Affiliations

    • Center for Cardiovascular Disease Prevention, Division of Cardiovascular Medicine, VA Boston Medical Center, Boston, Mass
    • Donald W. Reynolds Center for Cardiovascular Research, Boston, Mass
    • Leducq Center for Molecular and Genetic Epidemiology of Cardiovascular Disorders, Boston, Mass
    • Division of Cardiology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass

References 

  1. Koenig RJ, Peterson CM, Jones RL, et al. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med. 1976;295:417–420
  2. Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care. 1995;18:440–447
  3. Little RR. Glycated hemoglobin standardization—National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med. 2003;41:1191–1198
  4. Little RR, England JD, Wiedmeyer HM, et al. Glycated haemoglobin predicts progression to diabetes mellitus in Pima Indians with impaired glucose tolerance. Diabetologia. 1994;37:252–256
  5. Yoshinaga H, Kosaka K. High glycosylated hemoglobin levels increase the risk of progression to diabetes mellitus in subjects with glucose intolerance. Diabetes Res Clin Pract. 1996;31:71–79
  6. Narayan KM, Hanson RL, Pettitt DJ, et al. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM. Diabetes Care. 1996;19:972–978
  7. Ko GT, Chan JC, Tsang LW, Cockram CS. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care. 2000;23:1770–1773
  8. Park S, Barrett-Connor E, Wingard DL, et al. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes (The Rancho Bernardo Study). Diabetes Care. 1996;19:450–456
  9. de Vegt F, Dekker JM, Ruhe HG, et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia. 1999;42:926–931
  10. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ. 2001;322:15–18
  11. Meigs JB, Nathan DM, D’Agostino RB, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002;25:1845–1850
  12. Khaw KT, Wareham N, Bingham S, et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141:413–420
  13. Blake GJ, Pradhan AD, Manson JE, et al. Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med. 2004;164:757–761
  14. Ohlson LO, Svardsudd K, Welin L, et al. Fasting blood glucose and risk of coronary heart disease, stroke, and all-cause mortality: a 17-year follow-up study of men born in 1913. Diabet Med. 1986;3:33–37
  15. Balkau B, Shipley M, Jarrett RJ, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men (20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study). Diabetes Care. 1998;21:360–367
  16. Scheidt-Nave C, Barrett-Connor E, Wingard DL, et al. Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am J Epidemiol. 1991;133:565–576
  17. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events (A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years). Diabetes Care. 1999;22:233–240
  18. Fuller JH, Shipley MJ, Rose G, et al. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed). 1983;287:867–870
  19. Perry IJ, Wannamethee SG, Whincup PH, Shaper AG. Asymptomatic hyperglycaemia and major ischaemic heart disease events in Britain. J Epidemiol Community Health. 1994;48:538–542
  20. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293–1304
  21. Weinstein AR, Sesso HD, Lee IM, et al. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA. 2004;292:1188–1194
  22. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327–334
  23. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197
  24. Standards of medical care in diabetes—2006. Diabetes Care. 2006;29(Suppl 1):S4–S42
  25. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels (Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels). JAMA. 1996;276:1246–1252
  26. http://www.cdc.gov/diabetes/statistics/incidence/table5.htm. Last accessed May 21, 2007.
  27. Brownlee M. Lilly Lecture 1993 (Glycation and diabetic complications). Diabetes. 1994;43:836–841
  28. Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis?. Eur Heart J. 2002;23:831–834
  29. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2005;28(Suppl 1):S37–S42
  30. Ganda OP, Day JL, Soeldner JS, et al. Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes. 1978;27:715–725
  31. Cummings ST, Fraser CG. Variability of capillary plasma glucose in healthy individuals in repeated 75 g oral glucose tolerance tests. Ann Clin Biochem. 1988;25(Pt 6):634–637
  32. Ko GT, Chan JC, Woo J, et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem. 1998;35(Pt 1):62–67
  33. Dunn PJ, Cole RA, Soeldner JS, Gleason RE. Reproducibility of hemoglobin AIc and sensitivity to various degrees of glucose intolerance. Ann Intern Med. 1979;91:390–396
  34. Meigs JB, Nathan DM, Cupples LA, et al. Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol. 1996;49:411–417
  35. Rohlfing CL, Little RR, Wiedmeyer HM, et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care. 2000;23:187–191
  36. Anand SS, Razak F, Vuksan V, et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care. 2003;26:290–296
  37. Modan M, Halkin H, Karasik A, Lusky A. Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. Am J Epidemiol. 1984;119:431–444
  38. Davidson MB, Schriger DL, Peters AL, Lorber B. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA. 1999;281:1203–1210
  39. Simon D, Senan C, Balkau B, et al. Reproducibility of HbA1c in a healthy adult population: the Telecom Study. Diabetes Care. 1999;22:1361–1363

 Supported by grants from the National Heart, Lung, and Blood Institute (HL58755 and HL43851) and the National Cancer Institute (CA47988) and the Donald W. Reynolds Foundation. Blood specimen analysis supported by funds from Aventis, Inc.

PII: S0002-9343(07)00452-4

doi: 10.1016/j.amjmed.2007.03.022

The American Journal of Medicine
Volume 120, Issue 8 , Pages 720-727 , August 2007

Article Tools

* Image Usage & Resolution